Johnson & Johnson | search
Click here to view Johnson & Johnson news from 60+ newspapers.
Bookmark or Share- Heir to Johnson & Johnson fortune dies at 76
- Berkshire Hathaway Buys Wells Fargo, DaVita HealthCare, Mondelez, Sells Kraft Foods, Johnson & Johnson
- J&J will remove dangerous chemicals from products by 2015
- Hormone Drug Slows Prostate Cancer Growth
- DealBook: Avon Appoints New Chief Executive
More
- Investor Relations | Johnson & JohnsonAt Johnson & Johnson, we believe health is everything. We are building a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal. About Johnson & Johnson
- Johnson & Johnson Reports Q3 2024 Results | Johnson & JohnsonNEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2024. “Johnson & Johnson’s strong results in the third quarter reflect the unique breadth of our business and commitment to delivering the next wave of healthcare innovation,” said Joaquin Duato, Chairman and Chief Executive Officer.
- Johnson & Johnson’s Origin: Pioneering Healthcare Since 1886Explore the origins of Johnson & Johnson, founded in 1886 to revolutionize healthcare with innovative products and a commitment to improving global well-being.
- Johnson & Johnson: Changing health for humanityParadigm-shifting new therapies are helping people with the disease lead longer, more comfortable lives. Learn how Johnson & Johnson is helping to change the treatment landscape.
- Careers at J&JWorking with Johnson & Johnson can change everything—including you. Explore impactful jobs, inclusive employee benefits and how you can join us.
- More
